Dr. Bril is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2000 6th Ave S
Birmingham, AL 35233Phone+1 205-934-9999Fax+1 205-975-6424
Education & Training
OtherClass of 2007
Certifications & Licensure
AL State Medical License 2020 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 145 citationsThe role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver diseaseMaryann Maximos, Fernando Bril, Paola Portillo Sanchez, Romina Lomonaco, Beverly Orsak
Hepatology. 2015-01-01 - 27 citationsImpact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis.Srilaxmi Kalavalapalli, Fernando Bril, Joy Guingab, Ariana Vergara, Timothy J. Garrett
The Journal of Endocrinology. 2019-06-01 - 142 citationsResponse to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 DiabetesFernando Bril, Srilaxmi Kalavalapalli, Virginia Clark, Romina Lomonaco, Consuelo Soldevila-Pico
Clinical Gastroenterology and Hepatology. 2017-12-01
Press Mentions
PracticeUpdateDecember 3rd, 2020
FDA Approves Rezdiffra, the First Drug for Diabetes-Related Liver DiseaseMarch 16th, 2024
Professional Memberships
- Member
- Member
External Links
- Publonshttps://publons.com/researcher/1216548/fernando-bril/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
